Cencora
240.33
4.24 (1.80%)
At close: Jan 14, 2025, 3:59 PM
240.05
-0.12%
After-hours Jan 14, 2025, 07:00 PM EST
undefined%
Bid 222.58
Market Cap 46.45B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) 7.53
PE Ratio (ttm) 31.92
Forward PE n/a
Analyst Buy
Ask 248
Volume 917,928
Avg. Volume (20D) 1,235,440
Open 237.69
Previous Close 236.09
Day's Range 235.89 - 240.63
52-Week Range 214.77 - 253.27
Beta undefined

About COR

Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pha...

Sector Healthcare
IPO Date Apr 4, 1995
Employees 46,000
Stock Exchange NYSE
Ticker Symbol COR

Analyst Forecast

According to 10 analyst ratings, the average rating for COR stock is "Buy." The 12-month stock price forecast is $282.5, which is an increase of 17.55% from the latest price.

Buy 70.00%
Hold 30.00%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Cencora is scheduled to release its earnings on Feb 5, 2025, before market opens.
Analysts project revenue of $78.22B, reflecting a 8.26% YoY growth and earnings per share of 3.51, making a 7.01% increase YoY.
5 months ago · Source
+2.96%
Cencora shares are trading higher after the compan... Unlock content with Pro Subscription
6 months ago · Source
-3.93%
Cencora shares are trading lower after Walgreens lowered its outlook and announced store closure.